STOCK MARKET BSE NSE

Experimental coronavirus drug remdesivir effective in monkeys: Study

It involved two groups of six rhesus macaques that were deliberately infected with SARS-CoV-2.

Published: 18th April 2020 01:37 PM  |   Last Updated: 18th April 2020 04:58 PM   |  A+A-

MONKEY

Representational image (Photo | EPS)

By AFP

WASHINGTON: The experimental antiviral drug remdesivir has proven effective against COVID-19 in a small experiment involving monkeys, US government scientists reported Friday.

The study, which is preliminary and has not yet been peer reviewed, was designed to follow dosing and treatment procedures used for hospitalized COVID-19 patients in a large human trial.

It involved two groups of six rhesus macaques that were deliberately infected with SARS-CoV-2. One group received the drug, which was developed by Gilead Sciences, and the other group did not. 

FOLLOW COVID-19 LIVE UPDATES HERE

The group receiving the drug got their first intravenous dose 12 hours after infection then every day subsequently for six days.

The scientists timed the initial treatment to occur shortly before the virus reached its highest levels in the animals' lungs.

The treated animals showed significant improvement 12 hours after their first dose, a trend that continued over the week-long study.

One of the six treated animals showed mild breathing difficulty, while all six of the untreated monkeys had rapid and difficult breathing. 

The amount of virus found in the lungs was significantly lower in the treated group compared to the untreated group.

The treated group also had less lung damage.

Remdesivir was among the first drugs mooted as a treatment for the novel coronavirus and its randomized clinical trials are at an advanced stage. 

The health news website Stat on Thursday reported the drug had shown great efficacy at a Chicago hospital where patients who are part of those trials are being treated. 

Remdesivir causes the virus to add  mutations that can destroy it.

Stay up to date on all the latest Nation news with The New Indian Express App. Download now

Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp